ACCESS Newswire
06 Sep 2019, 14:49 GMT+10
HAMBURG, GERMANY / ACCESSWIRE / September 6, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at and attending the following upcoming conferences:
J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK
- Date: Wednesday, 11 September 2019
- Venue: London, UK
- Attendee: Enno Spillner, Chief Financial Officer
Bank of America Merrill Lynch Global Healthcare Conference 2019, London, UK
- Date: Wednesday, 18 September 2019,
Presentation: 18 September 2019, 4.25 pm BST
- Venue: London, UK
- Attendee: Werner Lanthaler, Chief Executive Officer
Baader Investment Conference, Munich, Germany
- Date: Monday, 23 September 2019,
Presentation: 23 September 2019, 5.15 pm CEST
- Venue: Munich, Germany
- Attendee: Enno Spillner, Chief Financial Officer
Berenberg and Goldman Sachs Eighth German Corporate Conference, Munich, Germany
- Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 2.30 pm CEST
- Venue: Munich, Germany
- Attendee: Enno Spillner, Chief Financial Officer
Ladenburg Thalmann Healthcare Conference, New York, NY, USA
- Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 10.30 am EDT
- Venue: New York, NY, USA
- Attendee: Dr Werner Lanthaler, Chief Executive Officer
2019 Cantor Global Healthcare Conference, New York, NY, USA
- Date: Wednesday, 02 October 2019,
Presentation: 02 October 2019, 3.00 pm EDT
- Venue: New York, NY, USA
- Attendee: Dr Werner Lanthaler, Chief Executive Officer
ABOUT EVOTEC SE
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,800 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry's need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others. For additional information please go to www.evotec.com and follow us on Twitter @Evotec.
FORWARD LOOKING STATEMENTS
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.
Contact Evotec SE:
Gabriele Hansen, VP Corporate Communications, Marketing & Investor Relations, Phone: +49.(0)40.56081-255, [email protected]
SOURCE: Evotec AG
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationHONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
NEW YORK, New York - Monday's trading session saw mixed performances across U.S. and global markets, with several major indices posting...
WASHINGTON, D.C.: The U.S. government has granted GE Aerospace permission to resume jet engine shipments to China's COMAC, a person...
DUBAI, U.A.E.: Saudi Aramco is exploring asset sales as part of a broader push to unlock capital, with gas-fired power plants among...
MILAN, Italy: Italian regulators have flagged four non-EU countries—including Russia—as carrying systemic financial risk for domestic...
NEW YORK CITY, New York: With just weeks to spare before a potential government default, U.S. lawmakers passed a sweeping tax and spending...
(Photo credit: Paul Rutherford-Imagn Images) The Boston Red Sox are facing a light portion of their schedule and taking advantage...
(Photo credit: Thomas Shea-Imagn Images) Brayan Rocchio lined a go-ahead, two-run double into the left field corner with two outs...
(Photo credit: Joe Camporeale-Imagn Images) Janson Junk held the Cincinnati Reds to one hit over six innings and Agustin Ramirez...
(Photo credit: Thomas Shea-Imagn Images) Brayan Rocchio lined a go-ahead, two-run double into the left-field corner with two outs...
(Photo credit: Bruce Kluckhohn-Imagn Images) Byron Buxton has solidified his status as a two-time All-Star for the Minnesota Twins....
(Photo credit: Matt Marton-Imagn Images) The Atlanta Hawks officially welcomed Kristaps Porzingis on Monday while waiving forward...